Gala Early Feasibility Study of RheOx

Clinical trial NCT03631472 · UNKNOWN

Trial details

NCT number: NCT03631472
Sponsor: Gala Therapeutics, Inc.
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Chronic Bronchitis Copd Bronchitis

Start date: 2018-07-06
Primary completion: 2021-01-30
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.